STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,827,000 | +2.1% | 360,000 | 0.0% | 0.15% | -1.3% |
| Q3 2019 | $3,748,000 | -32.0% | 360,000 | 0.0% | 0.15% | -32.7% |
| Q2 2019 | $5,515,000 | +7.3% | 360,000 | -10.0% | 0.22% | +6.2% |
| Q1 2019 | $5,140,000 | +35.3% | 400,000 | 0.0% | 0.21% | +48.9% |
| Q4 2018 | $3,800,000 | -42.8% | 400,000 | 0.0% | 0.14% | -18.5% |
| Q3 2018 | $6,640,000 | +3.4% | 400,000 | 0.0% | 0.17% | +27.2% |
| Q2 2018 | $6,420,000 | +4.9% | 400,000 | 0.0% | 0.14% | +76.6% |
| Q1 2018 | $6,120,000 | +96.2% | 400,000 | +100.0% | 0.08% | +63.8% |
| Q4 2017 | $3,120,000 | +12.4% | 200,000 | -20.0% | 0.05% | -2.1% |
| Q3 2017 | $2,775,000 | +20.7% | 250,000 | 0.0% | 0.05% | +20.0% |
| Q2 2017 | $2,300,000 | +169.0% | 250,000 | +150.0% | 0.04% | +110.5% |
| Q1 2017 | $855,000 | -59.6% | 100,000 | -41.2% | 0.02% | -75.6% |
| Q3 2014 | $2,118,000 | -15.1% | 170,000 | 0.0% | 0.08% | -22.8% |
| Q2 2014 | $2,494,000 | -21.0% | 170,000 | +9.7% | 0.10% | -11.4% |
| Q1 2014 | $3,156,000 | -5.3% | 155,000 | -8.8% | 0.11% | -4.2% |
| Q4 2013 | $3,332,000 | – | 170,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|